Showing results (191-200 of 296) with videos related to
Sort By:
Pageof 30
Cancers|November 4, 2020
The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept StudyMatteo Bauckneht, Sara Elena Rebuzzi, Alessio Signori, et al.Journal of Clinical Medicine|March 11, 2023
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World EvidenceElisabetta Signoriello, Giacomo Lus, Francesco Saccà, et al.Annals of Medicine|November 27, 2023
Early diagnosis of candidemia with explainable machine learning on automatically extracted laboratory and microbiological data: results of the AUTO-CAND projectDaniele Roberto Giacobbe, Cristina Marelli, Sara Mora, et al.Annals of Neurology|April 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort StudyPaolo Antonio Muraro, Antonio Zito, Alessio Signori, et al.Haematologica|January 25, 2015
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisAndrea Bacigalupo, Gerard Socié, Rose Marie Hamladji, et al.Immunotherapy|August 6, 2024
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 studyShobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, et al.British Journal of Haematology|January 9, 2013
Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expressionSarah Pozzi, Simona Geroldi, Elisabetta Tedone, et al.Therapeutic Advances in Medical Oncology|March 3, 2022
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinibSara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, et al.Blood Advances|December 17, 2021
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantationElisabetta Metafuni, Irene Maria Cavattoni, Teresa Lamparelli, et al.European Radiology|March 9, 2023
Combined forced diuresis and late acquisition on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented studyMatteo Bauckneht, Alberto Miceli, Alessio Signori, et al.Pageof 30